In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Economics of Chronic Diseases (EConDA)

The European Society of Cardiology (ESC) was an associated partner in 'Economics of Chronic Diseases (EConDA)', a 2 ½ -year (April 2013 - October 2015) project co-funded by the European Commission Public Health Programme. 

The project's key aim was to aid EU Member States to develop, select and implement more cost-effective policies to improve chronic disease prevention and impact upon populations with the highest rates of premature deaths from chronic diseases and reduce health inequalities.

Further information about the project is available on the project's website here

Read the press release: "EU Project unveils obesity and smoking trends across Europe and shows how primary prevention is the key to a healthy future"



1. Seek consensus among relevant experts, policy makers and international organisations on the methodology for measuring cost-effectiveness of interventions to prevent, screen and treat chronic diseases taking into consideration the cost of externalities.

2. Develop a demonstration model for integrated approaches to address cost-effectiveness of various interventions for chronic disease prevention, particularly to demonstrate the differential effects of interventions on various population sub groups.


PROJECT Consortium

Associated Partners: UK Health Forum (Project Leader), European Heart Network (Belgium), European Society of Cardiology (France), Health Equalities Group (UK), International Diabetes Federation Europe (Belgium), Lithuanian University of Health Sciences (Lithuania), National Institute of Health Dr Ricardo Jorge, IP (Portugal), University of Groningen (Netherlands)

Collaborating Partners: World Health Organization, Organisation of Economic Cooperation and Development, European Society for Medical Oncology (Switzerland), European Cancer Organisation (Belgium), European Respiratory Society (Belgium), European Kidney Health Alliance (Belgium), European Association for the Study of the Liver (Switzerland), University of Helsinki (Finland), Foundation of European Nurses in Diabetes (UK)